The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

Clinicians have traditionally used clinicopathological (CP) factors to determine locoregional recurrence (LR) risk of breast cancer and have generated the IBTR! nomogram to predict the risk of ipsilateral breast tumor recurrence (IBTR). The 21-gene recurrence score (RS) assay was recently correlated...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Springerplus
Päätekijät: Thaker, Nikhil G, Hoffman, Karen E, Stauder, Michael C, Shaitelman, Simona F, Strom, Eric A, Tereffe, Welela, Smith, Benjamin D, Perkins, George H, Huo, Lei, Munsell, Mark F, Pusztai, Lajos, Buchholz, Thomas A, Woodward, Wendy A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318826/
https://ncbi.nlm.nih.gov/pubmed/25674496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-0840-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia